Trajectories of early growth and subsequent lung function in cystic fibrosis: An observational study using UK and

Amy Macdougall1, Deborah Jarvis1, Ruth H Keogh2

  • 1National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Insights

Early childhood weight gain in Cystic Fibrosis (CF) patients is linked to better lung function. Tracking weight trajectories from age 1 is crucial for predicting future pulmonary health in children with CF.

Area of Science:

  • Pediatric Pulmonology
  • Nutritional Science
  • Biostatistics

Background:

  • Early life nutritional status impacts pulmonary health in pediatric Cystic Fibrosis (CF) patients.
  • National registry data enables studying individual weight gain patterns and their link to lung function in children with CF.

Purpose of the Study:

  • To investigate the relationship between early weight trajectories and lung function at age 6 in children with CF.
  • To inform clinical care by understanding how nutritional assessment guides management.

Main Methods:

  • Utilized UK and Canadian CF Registry data.
  • Employed mixed-effects linear regression to model weight and BMI z-score trajectories from age 1 to 5.
  • Used intercept (weight at age 1) and slope (weight trajectory) as covariates for lung function at age 6.

Main Results:

  • Greater weight-for-age z-score at age 1 and increased weight change over time correlated with higher FEV1% predicted in both UK and Canadian cohorts.
  • These associations were consistent for BMI z-scores and FVC% predicted.

Conclusions:

  • Early weight-for-age (at 1 year) and its trajectory in early childhood are associated with subsequent lung function in CF patients.
  • Current guidelines may need revision to emphasize weight tracking over specific percentile cut-offs.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
348
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
214
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
423
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K